Back to search
FDAFDA · Food and drugs·Recall number Z-1582-2018

AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use.

Published May 9, 2018 · Recall initiated: February 27, 2018

Summary

FDA records medical device Class II recall Z-1582-2018, published May 9, 2018 and initiated February 27, 2018. Recalling firm: Radiometer Medical ApS; Status: Terminated; Reported quantity: 2; Lot: Version 2.3.0 and 2.3.1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Radiometer Medical ApS
Distributor
US Nationwide Distribution in the states to Georgia and Wisconsin.
Lot
Version 2.3.0 and 2.3.1
Risk classification
Class II
Area (FDA)
device
Country
Denmark

Related recalls

Questions about this recall

Was AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use. recalled?

Yes. FDA published recall Z-1582-2018 on May 9, 2018. Reported hazard: There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.

What should I do if I have this product?

Voluntary: Firm initiated · Letter